0 results available. Select is focused ,type to refine list, press Down to open the menu,
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...
The following section summarizes insights on Johnson & Johnson's Fair Value Upside (FINBOX):
We've identified the following companies as similar to Johnson & Johnson because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Fair Value Upside (FINBOX) in the predictions category include:
The percentage increase (if positive) or decrease (if negative) that our models estimate over the current stock price.
Fair Value Upside represents the discount (if positive) or premium (if negative) implied by a company’s current stock price when compared to our estimate of intrinsic value. It is the inverse of Fair Value Downside
Upside = (Fair Value Estimate / Stock Price - 1)
The chart above depicts the distribution of fair value upside (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 2,320 companies were considered in this analysis, and 2,232 had meaningful values. The average fair value upside (finbox) of companies in the sector is 10.0% with a standard deviation of 24.8%.
Johnson & Johnson's Fair Value Upside (FINBOX) of 5.5% ranks in the 42.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,326 |
| Included Constituents | 2,232 |
| Min | -49.7% |
| Max | 66.3% |
| Median | 11.0% |
| Mean | 10.0% |
| Standard Deviation | 24.8% |
You can find companies with similar fair value upside (finbox) using this stock screener.